Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Preclinical data support development of lisofylline as a treatment for type 1 diabetes

March 29, 2005

New treatments for obesity described in patent literature

March 24, 2005

Roche reports agents for the treatment of diabetes

March 24, 2005

Genentech and Ipsen to develop sustained-release human growth hormone

March 24, 2005

New treatments for bone disorders reported in patent literature

March 22, 2005

Two CS-917 studies terminated after serious adverse events

March 22, 2005

Cetrorelix enters development for endometriosis and BPH

March 22, 2005

In vivo evidence that a 5-HT2A/2C receptor agonist elevates sexual activity

March 22, 2005

Methylene blue in the treatment of prolonged pharmaco-induced erection

March 22, 2005

Merck describes novel compounds for obesity and related eating disorders

March 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...